These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Interleukin-2 in malignant pleural mesothelioma (and adenocarcinoma of the lung). The use of intrapleural and continuous intravenous infusions: preliminary results. Thatcher N; Taylor P; Carroll KB; Loriaux EM; Palmer P; Franks CR Cancer Treat Rev; 1989 Jun; 16 Suppl A():161-2. PubMed ID: 2788503 [No Abstract] [Full Text] [Related]
5. High-dose methotrexate in the treatment of malignant mesothelioma of the pleura. A phase II study. Solheim OP; Saeter G; Finnanger AM; Stenwig AE Br J Cancer; 1992 Jun; 65(6):956-60. PubMed ID: 1616870 [TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study. Samson MK; Wasser LP; Borden EC; Wanebo HJ; Creech RH; Phillips M; Baker LH J Clin Oncol; 1987 Jan; 5(1):86-91. PubMed ID: 3543239 [TBL] [Abstract][Full Text] [Related]
7. Randomized trial of doxorubicin versus cyclophosphamide in diffuse malignant pleural mesothelioma. Sørensen PG; Bach F; Bork E; Hansen HH Cancer Treat Rep; 1985 Dec; 69(12):1431-2. PubMed ID: 3907825 [TBL] [Abstract][Full Text] [Related]
8. Malignant pleural mesothelioma in a child: long-term survival with ICE-WAC chemotherapy regimen. Mutafoğlu-Uysal K; Kargi A; Sarialioğlu F; Olgun N; Kovanlikaya A Turk J Pediatr; 2002; 44(3):244-7. PubMed ID: 12405438 [TBL] [Abstract][Full Text] [Related]
9. A case of repetitive intrapleural cancer chemotherapy using INFUSE-A-PORT for malignant mesothelioma. Omasa M; Hirata T; Shoji T; Bando T; Hasegawa S; Inui K; Wada H Thorac Cardiovasc Surg; 2001 Aug; 49(4):233-5. PubMed ID: 11505321 [TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy with cisplatin and/or doxorubicin in malignant mesothelioma. A retrospective study [corrected from prospective]. Tsavaris N; Primikirios N; Mylonakis N; Varouchakis G; Dosios T; Pavlidis N; Skarlos D; Tasopoulos T; Dritsas J; Kosmidis P Anticancer Res; 1997; 17(5B):3799-802. PubMed ID: 9427783 [TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of malignant diffuse mesothelioma. Kucuksu N; Thomas W; Ezdinli EZ Cancer; 1976 Mar; 37(3):1265-74. PubMed ID: 1260651 [TBL] [Abstract][Full Text] [Related]
13. Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma: a Phase II study. Astoul P; Picat-Joossen D; Viallat JR; Boutin C Cancer; 1998 Nov; 83(10):2099-104. PubMed ID: 9827714 [TBL] [Abstract][Full Text] [Related]
14. Malignant mesotheliomas and chemotherapy. Karakousis CP; Seddiq M; Moore R J Surg Oncol; 1980; 15(2):181-5. PubMed ID: 7421277 [TBL] [Abstract][Full Text] [Related]
16. Phase II trial of pralatrexate (10-propargyl-10-deazaaminopterin, PDX) in patients with unresectable malignant pleural mesothelioma. Krug LM; Heelan RT; Kris MG; Venkatraman E; Sirotnak FM J Thorac Oncol; 2007 Apr; 2(4):317-20. PubMed ID: 17409804 [TBL] [Abstract][Full Text] [Related]
17. Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients. Law MR; Gregor A; Hodson ME; Bloom HJ; Turner-Warwick M Thorax; 1984 Apr; 39(4):255-9. PubMed ID: 6426072 [TBL] [Abstract][Full Text] [Related]
18. Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B. Kindler HL; Herndon JE; Zhang C; Green MR; Lung Cancer; 2005 Jun; 48(3):423-8. PubMed ID: 15893012 [TBL] [Abstract][Full Text] [Related]
19. Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma: report of four cases. Monetti F; Casanova S; Grasso A; Cafferata MA; Ardizzoni A; Neumaier CE Lung Cancer; 2004 Jan; 43(1):71-4. PubMed ID: 14698539 [TBL] [Abstract][Full Text] [Related]
20. Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients. Castagneto B; Zai S; Mutti L; Lazzaro A; Ridolfi R; Piccolini E; Ardizzoni A; Fumagalli L; Valsuani G; Botta M Lung Cancer; 2001; 31(2-3):303-10. PubMed ID: 11165411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]